Skip to main content
Veterinary Medicines

Purevax FeLV (--) - Lyophilisate and solvent for suspension for injection

Not authorised
  • Canarypox virus, strain vCP97, expressing env and gag genes and a portion of the pol gene of Feline leukemia virus, Live

Product identification

Medicine name:
Purevax FeLV (--) - Lyophilisate and solvent for suspension for injection
Active substance:
  • Canarypox virus, strain vCP97, expressing env and gag genes and a portion of the pol gene of Feline leukemia virus, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canarypox virus, strain vCP97, expressing env and gag genes and a portion of the pol gene of Feline leukemia virus, Live
    Presentation_strength:≥10⁷·² CCID 50 Reference:Hse Index:0
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD
Authorisation status:
  • Surrendered
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 8/11/2024
Download
Bulgarian (PDF)
Published on: 8/11/2024
Croatian (PDF)
Published on: 8/11/2024
Czech (PDF)
Published on: 8/11/2024
Danish (PDF)
Published on: 8/11/2024
Dutch (PDF)
Published on: 8/11/2024
Estonian (PDF)
Published on: 8/11/2024
Finnish (PDF)
Published on: 8/11/2024
French (PDF)
Published on: 8/11/2024
German (PDF)
Published on: 8/11/2024
Greek (PDF)
Published on: 8/11/2024
Hungarian (PDF)
Published on: 8/11/2024
Icelandic (PDF)
Published on: 8/11/2024
Italian (PDF)
Published on: 8/11/2024
Latvian (PDF)
Published on: 8/11/2024
Lithuanian (PDF)
Published on: 8/11/2024
Maltese (PDF)
Published on: 8/11/2024
Norwegian (PDF)
Published on: 8/11/2024
Polish (PDF)
Published on: 8/11/2024
Portuguese (PDF)
Published on: 8/11/2024
Romanian (PDF)
Published on: 8/11/2024
Slovak (PDF)
Published on: 8/11/2024
Slovenian (PDF)
Published on: 8/11/2024
Spanish (PDF)
Published on: 8/11/2024
Swedish (PDF)
Published on: 8/11/2024